These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cyclooxygenase 2 and lipoxin A₄ in nasal polyps in cystic fibrosis. Rozsasi A, Heinemann A, Keck T. Am J Rhinol Allergy; 2011; 25(6):e251-4. PubMed ID: 22185734 [Abstract] [Full Text] [Related]
6. Histology of nasal polyps of different etiology. Sorensen H, Mygind N, Tygstrup I, Winge Flensborg E. Rhinology; 1977 Sep; 15(3):121-8. PubMed ID: 905718 [Abstract] [Full Text] [Related]
7. Expression, localization, and significance of vascular permeability/vascular endothelial growth factor in nasal polyps. Gosepath J, Brieger J, Lehr HA, Mann WJ. Am J Rhinol; 2005 Sep; 19(1):7-13. PubMed ID: 15794068 [Abstract] [Full Text] [Related]
11. [The concentration and expression of IL-5 in human nasal polyp tissue]. Xu R, Li Y, Xie M, Xu G, Zhang G, Wang S. Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Aug; 35(4):251-4. PubMed ID: 12768697 [Abstract] [Full Text] [Related]
12. Increased expression of interleukin-9, interleukin-9 receptor, and the calcium-activated chloride channel hCLCA1 in the upper airways of patients with cystic fibrosis. Hauber HP, Manoukian JJ, Nguyen LH, Sobol SE, Levitt RC, Holroyd KJ, McElvaney NG, Griffin S, Hamid Q. Laryngoscope; 2003 Jun; 113(6):1037-42. PubMed ID: 12782818 [Abstract] [Full Text] [Related]
17. IL-17A as a regulator of neutrophil survival in nasal polyp disease of patients with and without cystic fibrosis. Derycke L, Zhang N, Holtappels G, Dutré T, Bachert C. J Cyst Fibros; 2012 May; 11(3):193-200. PubMed ID: 22178076 [Abstract] [Full Text] [Related]